These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain. Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863 [TBL] [Abstract][Full Text] [Related]
26. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines. Rudraraju R; Mordant F; Subbarao K J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386 [No Abstract] [Full Text] [Related]
27. Letter: Influenza vaccination. Jackson-Moore EM Br Med J; 1975 Nov; 4(5994):461-2. PubMed ID: 1192125 [No Abstract] [Full Text] [Related]
28. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. Squarcione S; Sgricia S; Biasio LR; Perinetti E Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808 [TBL] [Abstract][Full Text] [Related]
29. Influenza vaccine response following its simultaneous application with BCG 1st report. Zykov MP; Raphaelskaya TI Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275 [TBL] [Abstract][Full Text] [Related]
30. Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigens. Mackenzie JS; Wetherall JD; Fimmel PJ; Hawkins BR; Dawkins RL Dev Biol Stand; 1977 Jun 1-3; 39():355-62. PubMed ID: 604120 [TBL] [Abstract][Full Text] [Related]
31. Purified viral neuraminidase vaccine to control influenza. Arora DJ Can Med Assoc J; 1979 Dec; 121(12):1575-9. PubMed ID: 394829 [TBL] [Abstract][Full Text] [Related]
32. The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines. MacKenzie JS; MacKenzie IH; Holt PG J Hyg (Lond); 1976 Dec; 77(3):409-17. PubMed ID: 1069819 [TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042 [TBL] [Abstract][Full Text] [Related]
34. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza]. Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100 [No Abstract] [Full Text] [Related]
35. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050 [TBL] [Abstract][Full Text] [Related]
36. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R; Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405 [TBL] [Abstract][Full Text] [Related]
37. Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease. Rocchi G; Ragona G; Piga C; Pelosio A; Volpi A; Vella S; Legniti N; de Felici A J Hyg (Lond); 1979 Dec; 83(3):383-90. PubMed ID: 512351 [TBL] [Abstract][Full Text] [Related]
38. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy. Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110 [TBL] [Abstract][Full Text] [Related]
39. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910 [TBL] [Abstract][Full Text] [Related]
40. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines]. Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]